Published in J Pediatr on June 23, 2012
Fetoscopic Repair of Isolated Fetal Spina Bifida | NCT03090633
Racial/ethnic differences in survival of United States children with birth defects: a population-based study. J Pediatr (2015) 1.15
Preventing kidney injury in children with neurogenic bladder dysfunction. Int J Prev Med (2013) 0.93
Role of health insurance on the survival of infants with congenital heart defects. Am J Public Health (2014) 0.87
Prospective and episodic memory in relation to hippocampal volume in adults with spina bifida myelomeningocele. Neuropsychology (2014) 0.77
A description of spina bifida cases and co-occurring malformations, 1976-2011. Am J Med Genet A (2013) 0.76
An FGF3-BMP Signaling Axis Regulates Caudal Neural Tube Closure, Neural Crest Specification and Anterior-Posterior Axis Extension. PLoS Genet (2016) 0.75
Retrospective Assessment of Cost Savings From Prevention: Folic Acid Fortification and Spina Bifida in the U.S. Am J Prev Med (2016) 0.75
Prenatal surgery for myelomeningocele: review of the literature and future directions. Childs Nerv Syst (2017) 0.75
Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA (2001) 5.33
Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics (2005) 4.91
National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol (2006) 4.08
Successful fetal surgery for spina bifida. Lancet (1998) 2.94
20-year survival of children born with congenital anomalies: a population-based study. Lancet (2010) 2.62
Infant mortality statistics from the 2005 period linked birth/infant death data set. Natl Vital Stat Rep (2008) 2.52
Spina bifida outcome: a 25-year prospective. Pediatr Neurosurg (2001) 2.38
Spina bifida. Lancet (2004) 2.02
Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics (2000) 1.85
Survival of infants with neural tube defects in the presence of folic acid fortification. Pediatrics (2006) 1.72
Survival and handicap of infants with spina bifida. Arch Dis Child (1980) 1.65
Etiology, pathogenesis and prevention of neural tube defects. Congenit Anom (Kyoto) (2006) 1.65
Prevalence of spina bifida among children and adolescents in 10 regions in the United States. Pediatrics (2010) 1.43
Racial/ethnic differences in the birth prevalence of spina bifida - United States, 1995-2005. MMWR Morb Mortal Wkly Rep (2009) 1.25
Long-term outcome in open spina bifida. Br J Gen Pract (2003) 1.22
Survival in infants with Down syndrome, Metropolitan Atlanta, 1979-1998. J Pediatr (2006) 1.14
Survival of infants with spina bifida: a population study, 1979-94. Paediatr Perinat Epidemiol (2001) 1.04
Racial/ethnic variations in the prevalence of selected major birth defects, metropolitan Atlanta, 1994-2005. Public Health Rep (2012) 0.97
Impact of including elective pregnancy terminations before 20 weeks gestation on birth defect rates. Teratology (2002) 0.84
Prevalence of spina bifida among children and adolescents in metropolitan Atlanta. Birth Defects Res A Clin Mol Teratol (2008) 0.81
Beyond multidisciplinary care: a new conceptual model for spina bifida services. Eur J Pediatr Surg (2000) 0.80
Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol (2010) 7.00
Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med (2014) 6.12
Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr (2008) 3.87
Ambient air pollution and risk of birth defects in Southern California. Am J Epidemiol (2002) 3.43
Reporting birth defects surveillance data 1968-2003. Birth Defects Res A Clin Mol Teratol (2007) 3.29
A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics (2003) 2.88
Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol (2007) 2.69
A review of the literature on the effects of ambient air pollution on fetal growth. Environ Res (2004) 2.49
Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med (2007) 2.43
Trends in the postfortification prevalence of spina bifida and anencephaly in the United States. Birth Defects Res A Clin Mol Teratol (2008) 2.35
Maternal occupational exposure to organic solvents during early pregnancy and risks of neural tube defects and orofacial clefts. Occup Environ Med (2012) 2.35
Neural tube defects and folate: case far from closed. Nat Rev Neurosci (2006) 2.30
Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation (2010) 2.26
Maternal exposure to ambient levels of benzene and neural tube defects among offspring: Texas, 1999-2004. Environ Health Perspect (2010) 2.16
Alcohol consumption by women before and during pregnancy. Matern Child Health J (2008) 1.94
Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology (2002) 1.94
Control selection and participation in an ongoing, population-based, case-control study of birth defects: the National Birth Defects Prevention Study. Am J Epidemiol (2009) 1.93
The importance of nomenclature for congenital cardiac disease: implications for research and evaluation. Cardiol Young (2008) 1.92
The continuing challenge of understanding, preventing, and treating neural tube defects. Science (2013) 1.86
Mortality in first 5 years in infants with functional single ventricle born in Texas, 1996 to 2003. Circulation (2010) 1.81
Differences in exposure assignment between conception and delivery: the impact of maternal mobility. Paediatr Perinat Epidemiol (2010) 1.76
Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol (2008) 1.69
The National Children's Study of environmental effects on child health and development. Environ Health Perspect (2003) 1.68
Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology (2007) 1.67
Prevalence of Down syndrome among children and adolescents in 10 regions of the United States. Pediatrics (2009) 1.66
Maternal smoking and the risk of orofacial clefts: Susceptibility with NAT1 and NAT2 polymorphisms. Epidemiology (2004) 1.63
Children's health and the environment: public health issues and challenges for risk assessment. Environ Health Perspect (2004) 1.61
The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention. Birth Defects Res A Clin Mol Teratol (2003) 1.58
Ambient air pollution and preterm birth: a time-series analysis. Epidemiology (2009) 1.57
Orofacial clefts in the National Birth Defects Prevention Study, 1997-2004. Am J Med Genet A (2009) 1.55
Schizencephaly: heterogeneous etiologies in a population of 4 million California births. Am J Med Genet A (2005) 1.55
Ambient air pollution and cardiovascular malformations in Atlanta, Georgia, 1986-2003. Am J Epidemiol (2009) 1.54
Quantifying geocode location error using GIS methods. Environ Health (2007) 1.48
Identification of novel candidate gene loci and increased sex chromosome aneuploidy among infants with conotruncal heart defects. Am J Med Genet A (2013) 1.48
Temporal trends in survival among infants with critical congenital heart defects. Pediatrics (2013) 1.45
Prevalence of spina bifida among children and adolescents in 10 regions in the United States. Pediatrics (2010) 1.43
Diacylglycerol kinase K variants impact hypospadias in a California study population. J Urol (2012) 1.43
Variation in prevalence of gestational diabetes mellitus among hospital discharges for obstetric delivery across 23 states in the United States. Diabetes Care (2012) 1.43
Epidemiologic characteristics of congenital diaphragmatic hernia among 2.5 million California births, 1989-1997. Birth Defects Res A Clin Mol Teratol (2006) 1.43
Antiherpetic medication use and the risk of gastroschisis: findings from the National Birth Defects Prevention Study, 1997-2007. Paediatr Perinat Epidemiol (2013) 1.40
Candidate gene sequencing of LHX2, HESX1, and SOX2 in a large schizencephaly cohort. Am J Med Genet A (2010) 1.40
International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ (2005) 1.39
Hypospadias in California: trends and descriptive epidemiology. Epidemiology (2003) 1.39
Does screening in the emergency department hurt or help victims of intimate partner violence? Ann Emerg Med (2008) 1.39
Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol (2009) 1.38
FRIL: A tool for comparative record linkage. AMIA Annu Symp Proc (2008) 1.38
Conjoined twins: a worldwide collaborative epidemiological study of the International Clearinghouse for Birth Defects Surveillance and Research. Am J Med Genet C Semin Med Genet (2011) 1.37
Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension (2009) 1.35
Racial differences in infant mortality attributable to birth defects in the United States, 1989-2002. Birth Defects Res A Clin Mol Teratol (2006) 1.34
Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol (2007) 1.34
Improving the quality of surveillance data on congenital heart defects in the metropolitan Atlanta congenital defects program. Birth Defects Res A Clin Mol Teratol (2007) 1.32
Neural tube defects and maternal residential proximity to agricultural pesticide applications. Am J Epidemiol (2006) 1.31
Anencephaly and spina bifida among Hispanics: maternal, sociodemographic, and acculturation factors in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2009) 1.31
Gastroschisis and associated defects: an international study. Am J Med Genet A (2007) 1.30
Array comparative genomic hybridization in patients with congenital diaphragmatic hernia: mapping of four CDH-critical regions and sequencing of candidate genes at 15q26.1-15q26.2. Eur J Hum Genet (2006) 1.29
Seasonality of birth and implications for temporal studies of preterm birth. Epidemiology (2009) 1.28
Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study. Pediatrics (2011) 1.28
Agenesis of the corpus callosum in California 1983-2003: a population-based study. Am J Med Genet A (2008) 1.25
Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol Genet Metab (2003) 1.25
Selected gene polymorphisms and their interaction with maternal smoking, as risk factors for gastroschisis. Birth Defects Res A Clin Mol Teratol (2006) 1.25
The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol (2011) 1.24
Residential mobility during pregnancy: patterns and correlates. Matern Child Health J (2009) 1.23
Comprehensive EMX2 genotyping of a large schizencephaly case series. Am J Med Genet A (2007) 1.22
Integration of DNA sample collection into a multi-site birth defects case-control study. Teratology (2002) 1.22
The association of ambient air pollution and traffic exposures with selected congenital anomalies in the San Joaquin Valley of California. Am J Epidemiol (2013) 1.21
Increasing prevalence of gastroschisis: population-based study in California. J Pediatr (2008) 1.21
Lexicon, definitions, and conceptual framework for public health surveillance. MMWR Surveill Summ (2012) 1.20
Bayesian methods for correcting misclassification: an example from birth defects epidemiology. Epidemiology (2009) 1.19
Frequency of holoprosencephaly in the International Clearinghouse Birth Defects Surveillance Systems: searching for population variations. Birth Defects Res A Clin Mol Teratol (2008) 1.18
Environmental and genetic contributors to hypospadias: a review of the epidemiologic evidence. Birth Defects Res A Clin Mol Teratol (2012) 1.17
Maternal age and prevalence of isolated congenital heart defects in an urban area of the United States. Am J Med Genet A (2011) 1.17
Folic acid in early pregnancy: a public health success story. FASEB J (2010) 1.16
Prenatal diagnosis, pregnancy terminations and prevalence of Down syndrome in Atlanta. Birth Defects Res A Clin Mol Teratol (2004) 1.16
Maternal occupational exposure to polycyclic aromatic hydrocarbons: effects on gastroschisis among offspring in the National Birth Defects Prevention Study. Environ Health Perspect (2012) 1.16
A genome-wide association study (GWAS) for bronchopulmonary dysplasia. Pediatrics (2013) 1.15
Maternal periconceptional smoking and alcohol consumption and risk for select congenital anomalies. Birth Defects Res A Clin Mol Teratol (2008) 1.15
Survival in infants with Down syndrome, Metropolitan Atlanta, 1979-1998. J Pediatr (2006) 1.14
Neural tube defects: an analysis of neighbourhood- and individual-level socio-economic characteristics. Paediatr Perinat Epidemiol (2009) 1.14
Sensitivity of birth certificate reports of birth defects in Atlanta, 1995-2005: effects of maternal, infant, and hospital characteristics. Public Health Rep (2011) 1.13
Maternal reproductive and demographic characteristics as risk factors for hypospadias. Paediatr Perinat Epidemiol (2007) 1.13